|
Synonyms: EYEOO1 | Macugen® | NX183 | pegaptanib sodium
pegaptanib is an approved drug (FDA (2004), EMA (2006))
Compound class:
Synthetic organic
Comment: Pegaptanib is a RNA oligonucleotide aptamer that cts as a vascular endothelial growth factor A antagonist, anti-angiogenic agent.
It is a 28-mer RNA aptamer that is covalently linked to two branched 20-kD polyethylene glycol (PEG) chains. |
| No information available. |
Summary of Clinical Use  |
| Used to treat neovascular (wet) age-related macular degeneration |
| Mechanism Of Action and Pharmacodynamic Effects |
| A pegylated anti-VEGF nucleic acid aptamer which inhibits angiogenesis and blood vessel permeability when administered intraoccularly (into the vitreous humor) |
| External links |
|
For extended ADME data see the following: Electronic Medicines Compendium (eMC) Drugs.com European Medicines Agency (EMA) |
